D.E. Shaw & Co’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

D.E. Shaw & Co’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-158,676	Closed	-$7.93K	–	4757
2023 Q3	$7.93K	Buy	+158,676	New	+$21.6K	﹤0.01%	4093
2022 Q3	–	Sell	-215,000	Closed	-$146K	–	5657
2022 Q2	$146K	Buy	+215,000	New	+$223K	﹤0.01%	4650

Other funds holding CANO.WS

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

D.E. Shaw & Co's CANO.WS Position: Q4 2023 in Review

D.E. Shaw & Co sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2023, closing a stake of 158,676 shares — an estimated $7.93K sold.

D.E. Shaw & Co first reported a position in CANO.WS in Q2 2022 and held it in 2 quarters. The position peaked at $146K in Q2 2022. 2 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2023.

D.E. Shaw & Co reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2023 after selling out during the quarter.
D.E. Shaw & Co sold 158,676 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2023, an estimated $7.93K.
D.E. Shaw & Co first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2022 and held it in 2 quarters.
D.E. Shaw & Co's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $146K in Q2 2022.
2 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.